Ultragenyx appoints general counsel

Ultragenyx Pharmaceutical, a clinical-stage biopharmaceutical company, has appointed Karah Parschauer as general counsel. In this newly created role, she will be responsible for leading the company's legal, compliance, and corporate governance functions.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.